<DOC>
	<DOCNO>NCT02977897</DOCNO>
	<brief_summary>Prospective , observational pilot study ten post-transplant patient present diarrhea take Mycophenolate Mofetil ( MMF ) . These patient undergo standard workup confirm MMF induce diarrhea . A stool fecal calprotectin measure determine may helpful confirm diagnosis MMF associate diarrhea . Once diagnosis confirm , patient treat short course subcutaneous Octreotide show cure type diarrhea .</brief_summary>
	<brief_title>Fecal Calprotectin Levels Mycophenolate Mofetil Induced Diarrhea Treatment With Octreotide</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Male female patient age 18 75 year old solid organ transplant recipient follow Toronto General Hospital MMF refer gastroenterology diarrhea . 1 . Subjects know history IBD GVHD bowel . 2 . Any subject receiving Octreotide another indication . 3 . Any patient unable undergo endoscopy . 4 . Any patient contraindication Octreotide therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Diarrhea</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Post-transplantation</keyword>
	<keyword>Octreotide</keyword>
	<keyword>Mycophenolate Mofetil</keyword>
	<keyword>Fecal Calprotectin</keyword>
</DOC>